IBO
Impact Biomedical Inc.Company with tickers: IBO
CIK
1834105
CUSIP
45259L205
Shares Outstanding
107,821,231
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $7,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $46,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-2,289,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-2,287,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |